This
announcement contains information which, prior to its disclosure,
was inside information as stipulated under Regulation 11 of the
Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as
amended). Upon the publication of this announcement via a
Regulatory Information Service, this inside information is now
considered to be in the public domain.
20/02/25

Valereum
Plc
("VLRM"
or the "Company")
Valereum Plc enters into
Binding Heads Of Terms for a Capital Raise of £19
Million with DMC Markets Inc. (Via Valereum Inc., an Entity Formed
for the Purpose of the Investment),
Four Strategic Investments
and
A Further £1 Million
Investment from a UK Institutional Investor
Valereum Plc (AQSE: VLRM) is pleased
to announce that it has entered into a binding Heads of Terms
("HoT") for a £19 million capital investment ("Investment") from
Valereum Inc., an entity formed for the purpose of the investment
from DMC Markets Inc. ("DMC"), the completion is subject to
finalising satisfactory due diligence. In addition to the
investment from DMC via Valereum Inc., acquiring 48.86% of Valereum
Plc, there will be an additional £1 million investment from a UK
institutional investor.
The HoT signed by the parties, as
being announced today, contain different terms from the
announcement made on 16 December 2024. Notably, DMC via Valereum
Inc. will now subscribe for a total of shares worth £19 million
(breakdown provided below), whereas the previous announcement
stated £13 million. This also includes their acquisition of the
shares originally intended to be issued to Blue Sky Vision LLC
("Blue Sky") under the option agreement announced by the Company on
16 December 2024 and 02 January 2025, with subsequent updates
provided on 14 February 2025, confirming that Blue Sky will not be
proceeding.
DMC's £19 Million Investment and Terms
Valereum Plc has agreed to issue
Valereum Inc. a total of 170,000,000 ordinary shares in the capital
of the Company (the "Subscription Shares"), allocated as
follows:
-
130,000,000 ordinary shares at an issue price of £0.10 per share
(as per the announcement made on 16 December 2024)
- 20,000,000
ordinary shares at an issue price of £0.20 per share
-
DMC Markets Inc., via its entity,
Valereum Inc. will acquire 20,000,000 ordinary shares at an issue price of £0.10 per
share, replacing the previously announced shares which were to be
issued to Blue Sky Vision LLC, as per the £2 million option
exercise announced on 02 January 2025, alongside the further update
to the market on 14 February 2025.
The proceeds of the Investment
will be used to make four strategic investments, to provide working
capital to support the investments and Valereum Plc's growth plans,
and to fund and accelerate the rollout of its tokenisation
and digital asset services.
Strategic
Asset Investments
Part of the proceeds of the Investment will
fund the acquisition of minority interests in four complementary
strategic assets which have been sourced by DMC ("Strategic
Investments"). Upon completion of the
Strategic Investments, Valereum Plc will have greater presence
across Australasia, Europe, North America and South America, as
well as accelerating the Group's provision of Web3, Tokenisation,
Defi, Asset Securitisation and Blockchain solutions.
Institutional
Investor £1m Investment and Terms
Valereum Plc also announces the
successful capital raise of an additional £1 million from an UK
based institutional investor. Under the agreement, Valereum Plc
will issue 5,000,000 ordinary shares at an issue price of £0.20 per
share. This additional capital injection provides the
Company with further working capital to support its growth
plans.
Admission of Shares
The Subscription Shares to be issued
to DMC via Valereum Inc. and the institutional investor are
expected to be admitted to trading on AQSE on or around 04 March
2025, subject to completion of the necessary issuance
procedures.
To discover more and for the chance to have
your questions directly answered by the management team, please
head to our interactive investor hub via: Investor Hub. Here
you will find company news and additional content to further
explain Valereum Plc's strategy and products.
For further
information, please contact:
Valereum
Plc
Peter Sekhon, Investor Relation
Director
Engage with the company directly
|
Tel: +44 7938
767319
Investor
Hub
|
Stanford
Capital Partners
Bob Pountney/ Patrick Claridge
|
Tel: +44 023 3650
3650
|
AQSE Corporate
Adviser
First Sentinel
Corporate Finance
Brian Stockbridge / Gabrielle
Cordeiro
|
Tel: +44 20 3855
5551
|
The Directors of the Company accept
responsibility for the contents of this announcement.
Please visit the Company's website at
www.vlrm.com or to engage with the
Valereum Plc management team directly by asking questions, watching
video
summaries and seeing what other shareholders have to
say:
Navigate to
our Interactive Investor
hub here: Sign
Up